1 of 3 listed pharmas with SG&A ration higher than 40%

1 of 3 listed pharmaceutical companies reportedly have a SG&A expense/sales ratio higher than 40%.

Yakup Shinmoon(www.yakup.com) analyzed 2018 1^st quarter business performances that 62 listed pharmaceutical companies recorded, and the analysis showed that they recorded a 28.4% ratio of SG&A(selling, general and administrative) expenses to sales on average. <holding and biotechnology companies ...